Vaccines have up to 90% efficacy against severe COVID-19 for up to six months
Scientists from Penn State found that protection against symptomatic COVID-19 begins to decrease after one month from initial vaccination, while immunity against severe COVID-19...
This anti-inflammatory compound may treat severe COVID-19
Scientists from the University of Texas Health Houston found an anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in...
Estrogen hormone may help prevent severe COVID-19 in women
In a recent study from the University of Helsinki, scientists found an older woman’s estrogen levels may be linked to her chances of dying...
COVID booster’s protection against omicron decreases a lot within 3 months
Scientists from the National Institutes of Health found that although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the omicron...
1 in 8 people with severe COVID-19 suffer from heart inflammation
In a recent study from the University of Glasgow, found one in eight people who were hospitalized with COVID-19 were later diagnosed with myocarditis...
Your genes and blood type may help predict severe COVID-19
In a recent study from the Severe COVID-19 GWAS Group, scientists found that a person’s genes and blood type may help determine their odds...
Yale develops new vaccine to offer better protection against omicron variants
Scientists from Yale have developed a novel omicron-specific mRNA vaccine that offers superior immune protection against two viral subvariants than standard mRNA vaccines.
The new...
What to know about the omicron subvariant driving up US COVID cases
Recent numbers from the Centers for Disease Control and Prevention show the BA.5 strain of omicron is now the dominant form of coronavirus in...
COVID-19 doubles risk of mental health and financial problems in older people
Scientists from the University College London found that people over the age of 52 appear to be twice as likely to develop mental health...
COVID antibodies could stay in the body for about 500 days, study finds
Scientists from the University of Texas found that adults who get COVID-19 could have antibodies circulating in their blood for nearly 500 days after...